Related Content
- The Little Clinic adds new insurance provider to accepted plans
- Gallup: Take Care Clinics top in customer service
- Bartell to cease filling Medicaid prescriptions at 15 locations
- With health reform outlook dimmed, pharmacy can’t abandon its agenda
- Rite Aid takes a bite out of obesity; relaunches weight-loss program for New Year
WASHINGTON Johnson & Johnson said Wednesday that it plans to ship limited quantities of one of its children's medicines following a nationwide recall.
J&J CEO William Weldon said nearly 1 million bottles of the medicine -- which he did not disclose -- will be available for release next week. The drug maker met with the House Committee on Oversight and Government Reform on Thursday to examine the circumstances surrounding J&J’s recall of more than 135 million bottles of infant and children’s medicines produced by Johnson & Johnson/McNeil Consumer Healthcare, including children’s Tylenol, infant’s Tylenol, children’s Motrin and children’s Benadryl.
On Sept. 16, J&J's consumer group chair Colleen Goggins said she would retire from her post on March 1, 2011.
